You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mixed Tumor, Mesodermal

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in United

Active, not recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +4 more
  • Computed Tomography
  • +5 more
  • Houston, Texas
  • +6 more
Dec 5, 2022

Molecular Epidemiology of Pediatric Germ Cell Tumors

Recruiting
  • Germ Cell Tumor
  • +8 more
  • Questionnaire Administration
  • +3 more
  • Minneapolis, Minnesota
    University of Minnesota
Nov 22, 2022

Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)

Not yet recruiting
  • Gynecologic Cancer
  • +3 more
  • Cabo + Dostarlimab
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jan 10, 2023

Breast Carcinoma, Endometrial Carcinoma, Prostate Carcinosarcoma Trial in Philadelphia (dietary supplement, other, procedure)

Completed
  • Breast Carcinoma
  • +2 more
  • Dietary Intervention
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Jan 4, 2023

Uterine Cancer Trial in Bronx (Ifosfamide, Radiation Therapy, Cisplatin)

Completed
Has Results
  • Uterine Cancer
  • Bronx, New York
    Montefiore Medical Center
Jan 3, 2019

Kidney Tumor Trial in Saint Petersburg (mixed reality technology in laparoscopic partial nephrectomy)

Completed
  • Kidney Tumor
  • mixed reality technology in laparoscopic partial nephrectomy
  • Saint Petersburg, Russian Federation
    Saint Petersburg State University Hospital
Aug 14, 2021

Ovarian Carcinosarcoma, Uterine Carcinosarcoma Trial (Eribulin Mesylate, Pembrolizumab)

Not yet recruiting
  • Ovarian Carcinosarcoma
  • Uterine Carcinosarcoma
  • (no location specified)
Jan 31, 2023

Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

Active, not recruiting
  • Oligodendroglioma
  • +5 more
  • GBM6-AD and poly-ICLC before and after surgery
  • GBM6-AD and poly-ICLC after surgery only
  • San Francisco, California
    University of California
Sep 20, 2022

Recurrent/Metastatic Carcinosarcoma Trial in Seoul (nivolumab)

Recruiting
  • Recurrent/Metastatic Carcinosarcoma
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Feb 3, 2022

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Ovarian Cancer, Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial (Pamiparib, Surufatinib)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
Aug 8, 2022

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Uterine Cancer Trial in Boston (AZD1775)

Recruiting
  • Uterine Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 5, 2022

Endometrial Cancer, Endometrial Carcinosarcoma, Endometrial Carcinoma Trial in United States (Durvalumab, Tremelimumab)

Completed
  • Endometrial Cancer
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

Suspended
  • Brenner Tumor
  • +27 more
  • metformin hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +9 more
May 16, 2022

Carcinosarcoma, Ovarian, Carcinosarcomas Uterine Trial in Rome (Trabectedin)

Completed
  • Carcinosarcoma, Ovarian
  • Carcinosarcomas Uterine
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Aug 24, 2021

Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

Active, not recruiting
  • Brain Tumor, Recurrent
  • +4 more
  • Cytoreductive surgery
  • +2 more
  • New York, New York
  • +1 more
Jun 9, 2022

ER+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer Trial in United States (BLU-222, Carboplatin, Ribociclib)

Recruiting
  • ER+ Breast Cancer
  • +8 more
  • Sarasota, Florida
  • +3 more
Jun 8, 2022

Mixed Tumor, Malignant Trial in United States (BAY806946)

Recruiting
  • Mixed Tumor, Malignant
  • Birmingham, Alabama
  • +20 more
Jan 20, 2023

Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)

Available
  • Esophageal Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +3 more
Aug 24, 2022

Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +14 more
  • Biopsy
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 28, 2023

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

Terminated
  • Ovarian Cancer
  • +21 more
  • Exercise Counseling
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 6, 2022

PD-1 Immunotherapy, VEGFR-TKI, Sarcomatoid Carcinoma Trial in Shanghai (Camrelizumab Combined With Apatinib)

Recruiting
  • PD-1 Immunotherapy
  • +3 more
  • Camrelizumab Combined With Apatinib
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 1, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in Boston (Paclitaxel, Carboplatin)

Terminated
Has Results
  • Ovarian Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Aug 10, 2018